Clinical Trials
12 trialsNCT07410676 2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2 Recruiting
NCT07335003 2026-01-12
Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses
Cosmetique Active International
Phase NA Recruiting
NCT05578872 2025-08-26
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
Anaveon AG
Phase 1/2 Completed
NCT05106192 2025-06-12
Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT06488365 2025-03-11
Cytophone
Cytoastra
Phase NA Recruiting
NCT05075356 2024-05-14
iToBoS
The University of Queensland
Phase NA Unknown
NCT04904120 2023-11-07
TIMAR1
Perspective Therapeutics
Phase 1 Completed
NCT04986696 2023-09-21
IMPulse
Centre Hospitalier Universitaire Vaudois
Phase NA Unknown
NCT04789421 2021-03-09
NET-DAM
Azienda Ospedaliero-Universitaria di Modena
Phase NA Completed
NCT02612168 2019-01-25
Melanoma Image Analysis Algorithm (MIAA) Validation Study
Skin Analytics Limited
Phase NA Completed
NCT03033485 2017-01-26
18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis
Xijing Hospital
Phase NA Unknown
NCT00748319 2012-08-22
KIR
Assistance Publique - Hôpitaux de Paris
Phase NA Completed